Skip to Content

  • Search

View Additional Section Content

A Phase III, Randomized, Placebo – Controlled, Parallel – Group, Double-Blind Clinical Trial to Study the Efficacy and Safety of MK-8931 (SCH 900931) in Subjects with Amnestic Mild Cognitive Impairment Due to Alzheimer’s Disease (Prodromal AD).

For more information on this trial, click the link below.

https://clinicaltrials.gov/ct2/show/NCT01953601?term=nct01953601&rank=1

Clinical Trial Categories

  • Alzheimer's Disease
Contact
Jennifer McGowan at 215-327-0161

Location

  • Abington Neurological Associates, Ltd

Find a Physician
Search Our Directory

215-481-MEDI

Schedule a
Test

215-481-EXAM

Clinical Trials Details